Search research articles
Contact Us
Filters
Showing results (91-100 of 122) with videos related to
Page
of 13
Sort By:
Neurology
|
September 14, 2019
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
Lana Zhovtis Ryerson, John Foley, Ih Chang, et al.
Radiology. Imaging Cancer
|
September 5, 2025
Evaluating Breast Cancer Intravoxel Incoherent Motion MRI Biomarkers across Software Platforms
Eric E Sigmund, Gene Y Cho, Dibash Basukala, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 8, 2021
Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients
Catherine Diefenbach, Jessica Caro, Akiko Koide, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 1, 2016
Prospective Randomized Trial of Prone Accelerated Intensity Modulated Breast Radiation Therapy With a Daily Versus Weekly Boost to the Tumor Bed
Benjamin T Cooper, George F Formenti-Ujlaki, Xiaochun Li, et al.
Neuro-Oncology
|
December 7, 2013
Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas
Matthias A Karajannis, Geneviève Legault, Mari Hagiwara, et al.
Breast Cancer Research : BCR
|
April 2, 2014
Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer
Jasmeet Singh, Yelena Novik, Stacey Stein, et al.
Plos One
|
July 7, 2012
CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort
Alissa K Greenberg, Feng Lu, Judith D Goldberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2012
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer
Sylvia Adams, Lina Kozhaya, Frank Martiniuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma
Elnaz F Firoz, Melanie Warycha, Jan Zakrzewski, et al.
Cancer Research
|
September 18, 2010
High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance
Natalie E Simpson, W Marcus Lambert, Renecia Watkins, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 122) with videos related to
Sort By:
Page
of 13
Neurology
|
September 14, 2019
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
Lana Zhovtis Ryerson, John Foley, Ih Chang, et al.
Radiology. Imaging Cancer
|
September 5, 2025
Evaluating Breast Cancer Intravoxel Incoherent Motion MRI Biomarkers across Software Platforms
Eric E Sigmund, Gene Y Cho, Dibash Basukala, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 8, 2021
Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients
Catherine Diefenbach, Jessica Caro, Akiko Koide, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 1, 2016
Prospective Randomized Trial of Prone Accelerated Intensity Modulated Breast Radiation Therapy With a Daily Versus Weekly Boost to the Tumor Bed
Benjamin T Cooper, George F Formenti-Ujlaki, Xiaochun Li, et al.
Neuro-Oncology
|
December 7, 2013
Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas
Matthias A Karajannis, Geneviève Legault, Mari Hagiwara, et al.
Breast Cancer Research : BCR
|
April 2, 2014
Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer
Jasmeet Singh, Yelena Novik, Stacey Stein, et al.
Plos One
|
July 7, 2012
CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort
Alissa K Greenberg, Feng Lu, Judith D Goldberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2012
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer
Sylvia Adams, Lina Kozhaya, Frank Martiniuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma
Elnaz F Firoz, Melanie Warycha, Jan Zakrzewski, et al.
Cancer Research
|
September 18, 2010
High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance
Natalie E Simpson, W Marcus Lambert, Renecia Watkins, et al.
Page
of 13